- Home
- ADPT vs EVTC Comparison
ADPT vs EVTC Comparison
Compare ADPT & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- EVTC
- Stock Information
- Founded
- ADPT 2009
- EVTC 1988
- Country
- ADPT United States
- EVTC United States
- Employees
- ADPT N/A
- EVTC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- EVTC EDP Services
- Sector
- ADPT Health Care
- EVTC Technology
- Exchange
- ADPT Nasdaq
- EVTC Nasdaq
- Market Cap
- ADPT 1.8B
- EVTC 2.1B
- IPO Year
- ADPT 2019
- EVTC 2013
- Fundamental
- Price
- ADPT $12.85
- EVTC $34.49
- Analyst Decision
- ADPT Strong Buy
- EVTC Hold
- Analyst Count
- ADPT 8
- EVTC 5
- Target Price
- ADPT $12.38
- EVTC $39.00
- AVG Volume (30 Days)
- ADPT 1.8M
- EVTC 294.8K
- Earning Date
- ADPT 08-05-2025
- EVTC 07-30-2025
- Dividend Yield
- ADPT N/A
- EVTC 0.58%
- EPS Growth
- ADPT N/A
- EVTC 102.95
- EPS
- ADPT N/A
- EVTC 2.13
- Revenue
- ADPT $205,216,000.00
- EVTC $886,589,000.00
- Revenue This Year
- ADPT $32.76
- EVTC $9.23
- Revenue Next Year
- ADPT $15.81
- EVTC $4.84
- P/E Ratio
- ADPT N/A
- EVTC $16.11
- Revenue Growth
- ADPT 21.60
- EVTC 12.93
- 52 Week Low
- ADPT $3.98
- EVTC $31.11
- 52 Week High
- ADPT $13.52
- EVTC $38.56
- Technical
- Relative Strength Index (RSI)
- ADPT 57.00
- EVTC 41.52
- Support Level
- ADPT $12.62
- EVTC $34.08
- Resistance Level
- ADPT $13.25
- EVTC $36.52
- Average True Range (ATR)
- ADPT 0.55
- EVTC 0.66
- MACD
- ADPT -0.05
- EVTC -0.28
- Stochastic Oscillator
- ADPT 58.13
- EVTC 12.42
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.